 Other physiologic endpoints included spirometry FVC and FEV1, assessed in the afternoon on Day -1 and Day 5, exhaled CO and NO measurements assessed in the afternoon on Days 1, 1, 3, and 5, and blood pressure and pulse rate assessed on Days -1 through 5 in the morning prior to the start of product administration and evening. 